Posts

Showing posts from October, 2021

Partially wide answers.

CURB your enthusiasm.

Where to draw the line?

DART through 2 weeks of treatment.

SABR-5.

Starting small.

The short of it.

HYPORT, bye eight weeks of treatment.

Forget 2019.

To TORS or not to TORS.

PROs and cons of short-term ADT.

Icky ipi.

EMBRACing the numbers.

Where are you registered?

Cuts are coming.

It starts local.

Early tell.

Xenophilia.

Oligometa-analysis.

Radiation pharmacist.

#ASTRO21.

Fewer fractions, more segments.

A signal for signet.

The beam dream.

Sleep compression.

PARP patrol.

Walmart medicine.

Into the breach.

Electing small volumes.

Approved.

Early converts

On the up and upfront.

Parasite oversight.

Stats to be left behind.

Leave it be.

Little by little.

On pelvic tilt.

Make room.

Dear John.

Sweet 15.

Standardizing treatment.